MedPath
HSA Approval

KESTINE TABLET 10 mg

SIN09435P

KESTINE TABLET 10 mg

KESTINE TABLET 10 mg

July 31, 1997

ZUELLIG PHARMA PTE. LTD.

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderEURODRUG LABORATORIES SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R06AX22

ebastine

Manufacturer Information

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

INDUSTRIAS FARMACEUTICAS ALMIRALL (IFA) S.A.-2nd Site

Active Ingredients

EBASTINE

10.00mg

Ebastine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KESTINE TABLET 10 mg - HSA Approval | MedPath